🇺🇸 FDA
Pipeline program

Botulinum Toxin Type B

AN072-401CD/NA

Approved mab completed

Quick answer

Botulinum Toxin Type B for Cervical Dystonia is a Approved program (mab) at SUPERNUS PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
SUPERNUS PHARMACEUTICALS, INC.
Indication
Cervical Dystonia
Phase
Approved
Modality
mab
Status
completed

Clinical trials